$MDGL
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ร agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Healthcare
Sector
Biotechnology
Industry
William J. Sibold
CEO
528
Employees
$399.63
Current Price
$10.55B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 1 | 5 | $35,023,032.10 | 91,806 | 81.30:1 |
| Sells | 1 | 1 | $430,800.00 | 1,077 | ||
| 2 weeks | Buys | 1 | 5 | $35,023,032.10 | 91,806 | 81.30:1 |
| Sells | 1 | 1 | $430,800.00 | 1,077 | ||
| 1 month | Buys | 1 | 5 | $35,023,032.10 | 91,806 | 81.30:1 |
| Sells | 1 | 1 | $430,800.00 | 1,077 | ||
| 2 months | Buys | 1 | 5 | $35,023,032.10 | 91,806 | 10.73:1 |
| Sells | 2 | 11 | $3,262,600.73 | 6,298 | ||
| 3 months | Buys | 1 | 5 | $35,023,032.10 | 91,806 | 4.99:1 |
| Sells | 2 | 26 | $7,011,938.23 | 13,324 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | BAKER BROS. ADVISORS LP Director | Purchase | 60,400 | $383.01 | $23,134,106.00 | View Details |
| Nov 4, 2026 | BAKER BROS. ADVISORS LP Director | Purchase | 5,586 | $366.99 | $2,050,018.43 | View Details |
| Nov 6, 2026 | BAKER BROS. ADVISORS LP Director | Purchase | 13,740 | $388.29 | $5,335,104.60 | View Details |
| Nov 6, 2026 | BAKER BROS. ADVISORS LP Director | Purchase | 2,000 | $396.61 | $793,220.00 | View Details |
| Nov 4, 2026 | BAKER BROS. ADVISORS LP Director | Purchase | 10,080 | $368.11 | $3,710,583.07 | View Details |
| Nov 6, 2026 | Kelley Shannon T General Counsel | Sale | 1,077 | $400.00 | $430,800.00 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 396 | $534.20 | $211,541.77 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 362 | $541.65 | $196,078.68 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 347 | $529.27 | $183,655.68 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 1,040 | $536.11 | $557,556.79 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 640 | $537.17 | $343,791.23 | View Details |
| Sep 11, 2026 | Sibold William John Director | Sale | 218 | $535.94 | $116,835.68 | View Details |
| Sep 11, 2026 | Sibold William John Director | Sale | 368 | $541.64 | $199,324.37 | View Details |
| Sep 11, 2026 | Sibold William John Director | Sale | 160 | $537.62 | $86,018.80 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 520 | $538.30 | $279,914.49 | View Details |
| Sep 11, 2026 | Sibold William John Director | Sale | 1,539 | $544.02 | $837,252.94 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 131 | $527.88 | $69,152.06 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 512 | $533.09 | $272,943.72 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 505 | $540.19 | $272,796.40 | View Details |
| Sep 9, 2026 | Sibold William John Director | Sale | 160 | $542.55 | $86,807.60 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.84
ActualN/A
Revenue
Estimated$404.72M
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: